This study investigates pancreatic cancer. The purpose of this study is to evaluate the use of an investigational medication combined with a chemotherapy regimen as postoperative treatment.
The study focuses on assessing the safety and effectiveness of this combination treatment. It evaluates how well patients tolerate the treatment and its impact on their health.
- Who can participate: Adults aged 18 and older who have had surgery for pancreatic cancer and meet specific health criteria can participate. Participants must not have received prior tumor treatment and must have adequate organ function.
- Study details: Participants will receive an investigational medication combined with chemotherapy.